CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 436-450 of 739
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
MinuteCE®How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Patient Case Study: Cancer-Associated Thrombosis
MinuteCE®Patient Case Study: Cancer-Associated Thrombosis
Don't Miss It! Rapid & Accurate AAV Diagnosis
MinuteCE®Don't Miss It! Rapid & Accurate AAV Diagnosis
Implementing the SOC Induction Therapies in AAV
MinuteCE®Implementing the SOC Induction Therapies in AAV
Optimizing AAV Outcomes: Maintenance Therapies
MinuteCE®Optimizing AAV Outcomes: Maintenance Therapies
- advertisement
Tailoring Treatment for Optimal Outcomes in Patients With AAV
MinuteCE®Tailoring Treatment for Optimal Outcomes in Patients With AAV
Elevating Care for Patients With Severe Renal Disease in AAV
MinuteCE®Elevating Care for Patients With Severe Renal Disease in AAV
Managing Patients With AAV in the Rheumatology Clinic
MinuteCE®Managing Patients With AAV in the Rheumatology Clinic
GA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
CME/CEGA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CEAdvancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
- advertisement
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
MinuteCE®Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
MinuteCE®HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
MinuteCE®Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC



















































